Lanzhou Foci Pharmaceutical Co Ltd (002644) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.041x

Based on the latest financial reports, Lanzhou Foci Pharmaceutical Co Ltd (002644) has a cash flow conversion efficiency ratio of 0.041x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥75.62 Million ≈ $11.07 Million USD) by net assets (CN¥1.85 Billion ≈ $270.12 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Lanzhou Foci Pharmaceutical Co Ltd worth for the company's overall valuation and market capitalisation.

Lanzhou Foci Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Lanzhou Foci Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Lanzhou Foci Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Lanzhou Foci Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore Lanzhou Foci Pharmaceutical Co Ltd (002644) cash flow quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Tianyang Hot Mel
SHG:603330
0.078x
Mercuries & Associates Holding Ltd
TW:2905
-0.043x
Beijing Career International Co Ltd
SHE:300662
0.059x
Goldcard High-Tech Co Ltd
SHE:300349
0.046x
John B Sanfilippo & Son Inc
NASDAQ:JBSS
0.001x
Zhejiang Aokang Shoes Co Ltd
SHG:603001
0.002x
Shuifa Energas Gas Co Ltd
SHG:603318
-0.019x
GeoPark Ltd
NYSE:GPRK
0.095x

Annual Cash Flow Conversion Efficiency for Lanzhou Foci Pharmaceutical Co Ltd (2007–2024)

The table below shows the annual cash flow conversion efficiency of Lanzhou Foci Pharmaceutical Co Ltd from 2007 to 2024. View 002644 stock price and chart for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥1.81 Billion
≈ $265.59 Million
CN¥38.98 Million
≈ $5.70 Million
0.021x -42.20%
2023-12-31 CN¥1.77 Billion
≈ $258.78 Million
CN¥65.71 Million
≈ $9.62 Million
0.037x -10.97%
2022-12-31 CN¥1.73 Billion
≈ $253.73 Million
CN¥72.37 Million
≈ $10.59 Million
0.042x +472.99%
2021-12-31 CN¥1.63 Billion
≈ $238.15 Million
CN¥11.85 Million
≈ $1.73 Million
0.007x -81.62%
2020-12-31 CN¥1.59 Billion
≈ $232.24 Million
CN¥62.89 Million
≈ $9.20 Million
0.040x +24.86%
2019-12-31 CN¥1.51 Billion
≈ $220.51 Million
CN¥47.82 Million
≈ $7.00 Million
0.032x +24.68%
2018-12-31 CN¥1.44 Billion
≈ $210.78 Million
CN¥36.66 Million
≈ $5.36 Million
0.025x -47.92%
2017-12-31 CN¥1.36 Billion
≈ $198.89 Million
CN¥66.42 Million
≈ $9.72 Million
0.049x +10.85%
2016-12-31 CN¥1.29 Billion
≈ $188.85 Million
CN¥56.90 Million
≈ $8.33 Million
0.044x -15.17%
2015-12-31 CN¥1.23 Billion
≈ $180.52 Million
CN¥64.11 Million
≈ $9.38 Million
0.052x -59.24%
2014-12-31 CN¥735.22 Million
≈ $107.59 Million
CN¥93.75 Million
≈ $13.72 Million
0.128x +956.24%
2013-12-31 CN¥703.37 Million
≈ $102.93 Million
CN¥-10.47 Million
≈ $-1.53 Million
-0.015x +8.69%
2012-12-31 CN¥675.53 Million
≈ $98.85 Million
CN¥-11.02 Million
≈ $-1.61 Million
-0.016x -535.65%
2011-12-31 CN¥648.08 Million
≈ $94.84 Million
CN¥2.43 Million
≈ $355.00K
0.004x -97.82%
2010-12-31 CN¥326.46 Million
≈ $47.77 Million
CN¥56.18 Million
≈ $8.22 Million
0.172x +1156.35%
2009-12-31 CN¥252.96 Million
≈ $37.02 Million
CN¥3.46 Million
≈ $507.01K
0.014x +392.85%
2008-12-31 CN¥216.81 Million
≈ $31.73 Million
CN¥602.56K
≈ $88.17K
0.003x -99.49%
2007-12-31 CN¥195.20 Million
≈ $28.56 Million
CN¥105.61 Million
≈ $15.45 Million
0.541x --

About Lanzhou Foci Pharmaceutical Co Ltd

SHE:002644 China Drug Manufacturers - Specialty & Generic
Market Cap
$612.00 Million
CN¥4.18 Billion CNY
Market Cap Rank
#11308 Global
#3171 in China
Share Price
CN¥8.19
Change (1 day)
-1.09%
52-Week Range
CN¥6.81 - CN¥10.02
All Time High
CN¥18.02
About

LanZhou Foci Pharmaceutical Co.,Ltd., research and development, production, and sales of traditional chinese medicines and health products in China. The company offers its products in various dosage forms, including pills, tablets, granules, capsules, and gelatin under the MingShan, BaoShu, BaoLu, and Foci brands. It also engages in planting and selling of Chinese medicinal materials; processing … Read more